As(III) S-adenosylmethionine methyltransferases and other arsenic binding proteins

A Abdul Ajees1, Barry P Rosen2

  • 1Department of Atomic and Molecular Physics, LG-01, Academic Block -5, MIT Campus, Manipal University, Manipal - 576 104, Karnataka, India.

Geomicrobiology Journal
|September 15, 2015
PubMed

Insights

Arsenic detoxification occurs via methylation by arsenic methyltransferase (AS3MT/ArsM) enzymes. This review examines the controversial methylation pathway and its implications for arsenic toxicity and carcinogenicity.

Area of Science:

  • Biochemistry
  • Environmental Toxicology
  • Molecular Biology

Background:

  • Arsenic detoxification primarily occurs through methylation catalyzed by arsenic methyltransferase (AS3MT/ArsM) enzymes.
  • AS3MT/ArsM enzymes are part of a larger methyltransferase superfamily with diverse physiological roles.
  • Over 5000 AS3MT/ArsM orthologues are documented in the NCBI database, predominantly in microbial organisms.

Purpose of the Study:

  • To review the biochemical mechanisms of arsenic methylation.
  • To examine the controversial pathway of arsenic methylation by AS3MT/ArsM enzymes.
  • To discuss the potential toxicity and carcinogenicity of methylated arsenic species.

Main Methods:

  • Literature review of existing research on AS3MT/ArsM enzymes.
  • Analysis of protein sequence data from the NCBI database.
  • Examination of various hypotheses regarding the arsenic methylation pathway.

Main Results:

  • Arsenic detoxification involves the conversion of inorganic arsenic (As(III)) into methylated forms by AS3MT/ArsM.
  • Methylated arsenic species may exhibit increased toxicity and carcinogenicity compared to inorganic arsenic.
  • The precise methylation pathway remains a subject of ongoing scientific debate.

Conclusions:

  • AS3MT/ArsM enzymes play a critical role in arsenic metabolism and detoxification across various organisms.
  • Understanding the methylation pathway is crucial for assessing the health risks associated with arsenic exposure.
  • Further research is needed to resolve the controversies surrounding the arsenic methylation pathway.

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
68
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
65
Phase II Reactions: Methylation Reactions01:17

Phase II Reactions: Methylation Reactions

Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
881
Sulfur Assimilation01:20

Sulfur Assimilation

Sulfur is an essential element in biological systems, contributing to synthesizing key biomolecules, including amino acids such as cysteine and methionine, and cofactors such as coenzyme A and biotin. Microorganisms primarily assimilate sulfur as sulfate (SO₄²⁻) from the environment, which must undergo a series of biochemical transformations before it can be incorporated into cellular components. As sulfate is highly oxidized, it must undergo assimilatory sulfate reduction to...
506
RNA Editing02:23

RNA Editing

RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
10.2K
Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
6.9K